Ignite Creation Date:
2025-12-24 @ 10:34 PM
Ignite Modification Date:
2026-06-20 @ 9:59 PM
Study NCT ID:
NCT06047535
Status:
NOT_YET_RECRUITING
Last Update Posted:
2023-09-21
First Post:
2023-09-12
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Naxitamab and Granulocyte-Macrophage Colony Stimulating Factor (GM-CSF) Combined With Isotretinoin for Maintenance Treatment of Patients With High-Risk Neuroblastoma in First Complete Response.
Sponsor:
SciClone Pharmaceuticals
Organization: